Skip to main content

Advertisement

Log in

Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Plasma HIV RNA level has been shown to correlate with HIV disease progression, morbidity, and mortality. We examined the association between levels of plasma HIV RNA and cognitive function among patients in Nigeria. A total of 179 HIV-1-infected participants with available plasma HIV RNA results and followed longitudinally for up to 2 years were included in this study. Blood samples from participants were used for the measurement of plasma HIV RNA and CD4+ T cell count. Utilizing demographic and practice effect-adjusted T scores obtained from a seven-domain neuropsychological test battery, cognitive status was determined by the global deficit score (GDS) approach, with a GDS ≥ 0.5 indicating cognitive impairment. In a longitudinal multivariable linear regression analysis, adjusting for CD4 cell count, Beck’s Depression Score, age, gender, years of education, and antiretroviral treatment status, global T scores decreased by 0.35 per log10 increase in plasma HIV RNA [p = 0.033]. Adjusting for the same variables in a multivariable logistic regression, the odds of neurocognitive impairment were 28% higher per log10 increase in plasma HIV RNA (OR 1.28 [95% CI 1.08, 1.51]; p = 0.005). There were statistically significant associations for the speed of information processing, executive, and verbal fluency domains in both linear and logistic regression analyses. We found a significant association between plasma HIV RNA levels and cognitive function in both baseline (cross-sectional) and longitudinal analyses. However, the latter was significantly attenuated due to weak association among antiretroviral-treated individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Akolo C, Royal W III, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A e, Blattner W (2014) Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. J Neurovirol 20(4):380–387

    Article  PubMed  PubMed Central  Google Scholar 

  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799

    Article  CAS  PubMed  Google Scholar 

  • Beck AT, Steer RA ,Brown GK (1996) Beck Depression Inventory San Antonio, TX, Psychological Corporation

  • Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK (2012) Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol 26(6):894–908

    Article  CAS  PubMed  Google Scholar 

  • Brew BJ, Chan P (2014) Update on HIV dementia and HIV-associated neurocognitive disorders. Curr Neurol Neurosci Rep 14(8):1–7

    Article  CAS  Google Scholar 

  • Camlin CS, Seeley J, Viljoen L, Vernooij E, Simwinga M, Reynolds L, Reis R, Plank R, Orne-Gliemann J, McGrath N, Larmarange J, Hoddinott G, Getahun M, Charlebois ED, Bond V (2016) Strengthening universal HIV ‘test-and-treat’ approaches with social science research. AIDS (London, England) 30(6):969–970

    Article  Google Scholar 

  • Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26(3):307–319

    Article  PubMed  Google Scholar 

  • Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999) Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52(3):607–613

    Article  CAS  PubMed  Google Scholar 

  • Connolly MA, Liang K-Y (1988) Conditional logistic regression models for correlated binary data. Biometrika 75(3):501–506

    Article  Google Scholar 

  • Cysique LA, Waters EK, Brew BJ (2011) Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. BMC Neurol 11(1):1–10

    Article  Google Scholar 

  • Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA (1997) Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol 42(5):679–688

    Article  CAS  PubMed  Google Scholar 

  • Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan J, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I (2002) Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus rna. Arch Neurol 59(6):923–928

    Article  PubMed  Google Scholar 

  • Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J (1998) Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12(8):F65–F70

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5(1):69–81

    Article  CAS  PubMed  Google Scholar 

  • Group T M E W (2013) Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis 56(7):1004–1017

    Article  Google Scholar 

  • Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087–2096

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3–16

    Article  CAS  PubMed  Google Scholar 

  • Henrard DR, Phillips JF, Muenz LR, Blattner WA, Wiesner D, Eyster ME, Goedert JJ (1995) Natural history of HIV-1 cell-free viremia. Jama 274(7):554–558

    Article  CAS  PubMed  Google Scholar 

  • Huang X, Chen H, Li W, Li H, Jin X, Perelson AS, Fox Z, Zhang T, Xu X, Wu H (2012) Precise determination of time to reach viral load set point after acute HIV-1 infection. J Acquir Immune Defic Syndr 61(4):448–454

    Article  PubMed  PubMed Central  Google Scholar 

  • Jumare J, Sunshine S, Ahmed H, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Umlauf A, Cherner M, Abimiku A, Charurat M, Li JZ, Blattner WA, Royal W 3rd (2017) Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria. J Neurovirol 27(10):017–0520

    Google Scholar 

  • Marcotte TD, Deutsch R, McCutchan J, Moore DJ, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I, San Diego HIV Neurobehavioral Research Center (HNRC) Group (2003) Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol 60(10):1406–1412

    Article  PubMed  Google Scholar 

  • McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997) Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 42(5):689–698

    Article  CAS  PubMed  Google Scholar 

  • Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272(5265):1167–1170

    Article  CAS  PubMed  Google Scholar 

  • Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20(1):25–31

    Article  PubMed  Google Scholar 

  • Price RW, Spudich S (2008) Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 15(197):533419

    Google Scholar 

  • Rao VR, Ruiz AP, Prasad VR (2014) Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther 11:13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rausch DM, Davis MR (2001) HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases. J Neurovirol 7(2):85–96

    Article  CAS  PubMed  Google Scholar 

  • Reger M, Welsh R, Razani J, Martin DJ, Boone KB (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 8(3):410–424

    Article  PubMed  Google Scholar 

  • Reger MA, Martin DJ, Cole SL, Strauss G (2005) The relationship between plasma viral load and neuropsychological functioning in HIV-1 infection. Arch Clin Neuropsychol 20(2):137–143

    Article  PubMed  Google Scholar 

  • Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C (1998) CSF, plasma viral load and HIV associated dementia. J Neurovirol 4(1):90–94

    Article  CAS  PubMed  Google Scholar 

  • Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA (2016) Associations between cognition, gender and monocyte activation among HIV infected individuals in Nigeria. PLoS One 11(2):e0147182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanford R, Fellows LK, Ances BM, Collins D (2018) Association of brain structure changes and cognitive function with combination antiretroviral therapy in HIV-positive individuals. JAMA Neurol 75(1):72–79

    Article  PubMed  Google Scholar 

  • Spudich S (2013) HIV and neurocognitive dysfunction. Curr HIV/AIDS Rep 10(3):235–243

    Article  PubMed  PubMed Central  Google Scholar 

  • Spudich S, González-Scarano F (2012) HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harbor Perspect Med 2(6):a007120

    Article  CAS  Google Scholar 

  • Stankoff B, Calvez V, Suarez S, Bossi P, Rosenblum O, Conquy L, Turell E, Dubard T, Coutellier A, Baril L, Bricaire F, Lacomblez L, Lubetzki C (1999) Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment. Eur J Neurol 6(6):669–675

    Article  CAS  PubMed  Google Scholar 

  • Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19(2):152–168

    Article  PubMed  PubMed Central  Google Scholar 

  • Zayyad Z, Spudich S (2015) Neuropathogenesis of HIV: from initial neuroinvasion to HIV associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep 12(1):16–24

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Financial Support

This work was supported by the National Institutes of Health grant no. R01 MH086356 (to William A. Blattner and Walter Royal, III) and by the National Institutes of Health Fogarty/AIDS International Training and Research Program grant no. 2D43TW001041-14 (training support to Jibreel Jumare).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter Royal III.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Disclaimer

This work was presented in part at the 19th Annual International Meeting of the Institute of Human Virology, 23rd-26th October 2017, Baltimore, Maryland, USA (Abstract P-D6).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jumare, J., El-Kamary, S.S., Magder, L. et al. Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria. J. Neurovirol. 24, 712–719 (2018). https://doi.org/10.1007/s13365-018-0667-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13365-018-0667-8

Keywords

Navigation